<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>COVID-19 Children with Suspected  or Confirmed Infection MeG-CLS-082</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="children-with-suspected-or-confirmed-covid-19-infection">Children with Suspected or Confirmed COVID-19 Infection</h1>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun"><em><strong>Executive summary</strong></em></span></p>
</div>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun"><strong>Introduction</strong></span></p>
</div>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun">Children appear to have a similar likelihood of contracting COVID-19 as adults do but the infection is associated with a less severe illness. Children with pre-existing medical conditions such as immunocompromise, heart disease, chronic kidney disease or respiratory problems may be more severely affected. Children may also have a mixed infection with another respiratory virus or a secondary bacterial infection. Most children should, however, recover 1-2 weeks after the onset of symptoms.</span></p>
</div>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun"><strong>Target User</strong></span></p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p><span data-custom-style="normaltextrun">Doctors</span></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><span data-custom-style="normaltextrun">Nurses</span></p>
</div></li>
</ul>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun"><strong>Target area of use</strong></span></p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p><span data-custom-style="normaltextrun">Ward</span></p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes  </h2>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun">Clinical care of patients under 16 years old with confirmed or suspected COVID-19 infection. Please see separate guideline for care of neonates, pregnant women and adults with COVID-19 as well as palliative care.</span></p>
</div>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun"><strong>Limitations</strong></span></p>
</div>
<div data-custom-style="paragraph">
<p><span data-custom-style="normaltextrun">The evidence base for managing COVID-19 infections is growing exponentially as we see more cases. For the most up to date information please see the links in the reference section below as our understanding and response to this disease will change over time. Currently we have no facilities for dedicated paediatric intensive care in The Gambia.</span></p>
</div>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p><span data-custom-style="normaltextrun">Children will most often present with fever and cough. Other less common symptoms include rhinitis, dyspnoea, cyanosis, fatigue, headache, poor feeding and diarrhoea. Diarrhoea appears to be more common in children. Most children will be asymptomatic or just have mild symptoms and not require admission to hospital. In severe cases it may present as pneumonia, bronchiolitis or sepsis.</span></p>
<h3 id="pneumonia">Pneumonia</h3>
<p><span data-custom-style="normaltextrun">Pneumonia is defined as: cough or difficulty breathing AND fast breathing</span></p>
<table>
<thead>
<tr class="header">
<th><strong>Definition of fast breathing as per WHO</strong></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>&lt;2 months old</td>
<td>≥ 60 breaths/min</td>
</tr>
<tr class="even">
<td>2-11 months old</td>
<td>≥ 50 breaths/min</td>
</tr>
<tr class="odd">
<td>1-5 years old</td>
<td>≥ 40 breaths/min</td>
</tr>
<tr class="even">
<td>&gt; 5 years old</td>
<td>&gt;20 breaths/min</td>
</tr>
</tbody>
</table>
<p><span data-custom-style="normaltextrun">Severe pneumonia is defined as:</span></p>
<p><span data-custom-style="normaltextrun">Cough or difficulty breathing plus at least one of the following:</span></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Central cyanosis or SpO2 &lt; 90%</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Severe respiratory distress (grunting or severe chest indrawing)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Inability to breastfeed or drink</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lethargic or unconscious</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Convulsions</p>
</div></li>
</ul>
<h3 id="septic-shock">Septic shock </h3>
<p><span data-custom-style="normaltextrun">Septic shock is defined in children as:</span></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Hypotension (systolic blood pressure [SBP] &lt; 5th centile or &gt; 2 SD below normal for age)</p>
</div></li>
</ul>
<p><span data-custom-style="normaltextrun">OR</span></p>
<p><span data-custom-style="normaltextrun">Two or more of the following:</span></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Altered mental state</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Bradycardia or tachycardia (HR &lt; 90 bpm or &gt; 160 bpm in infants and HR &lt; 70 bpm or &gt; 150 bpm in children</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Prolonged capillary refill (&gt; 2 sec) or feeble pulses</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Tachypnoea</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Mottled or cold skin or petechial or purpuric rash</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Increased lactate (not available at MRC lab)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Oliguria</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hyperthermia or hypothermia.</p>
</div></li>
</ul>
<h2 id="examination-findings">Examination findings</h2>
<p><span data-custom-style="normaltextrun">Do not routinely examine ANY children’s throats during the COVID-19 pandemic as there are likely to be asymptomatic patients with pharyngeal carriage which increases exposure for healthcare professionals. It is reasonable to prescribe antibiotics for a possible streptococcal infection on the basis of history alone at this time</span>.</p>
<p>Although most children will only have mild symptoms, it is important to specifically assess their:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Breathing: Respiratory rate, work of breathing, presence of severe chest indrawing, SpO2 level</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Circulation: Heart rate, central capillary re-fill time, BP if available</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hydration: Skin turgor, anterior fontanelle, mucous membranes</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Temperature and features of sepsis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Blood glucose level if history of poor feeding or vomiting</p>
</div></li>
</ul>
<h2 id="investigations">Investigations</h2>
<p>Please see SOP-AIR-007 for how to do nasopharyngeal and throat swabs to confirm infection.</p>
<h3 id="well-child">Well child</h3>
<p>There is no need to do any investigations for a child with confirmed COVID-19 who is well with mild symptoms.</p>
<h3 id="unwell-child">Unwell child </h3>
<p>If the child looks unwell (specifically with persistent fever, dehydration or suspected sepsis, signs of liver dysfunction or respiratory failure) then they should be investigated with full blood count, blood culture and renal function tests.</p>
<p>In COVID-19 you would typically see normal or reduced white cell count with low neutrophil and/or lymphocyte counts. Some patients will also have low platelets too. In severe cases there may be elevated liver enzymes, if these persist then check coagulation as this may also be deranged. Liver function tests should not routinely be checked.</p>
<p>Radiological changes in children may be non-specific. Chest X-rays may show bilateral patchy airspace consolidation at the periphery of the lungs, peribronchial thickening and ground-glass opacities. Chest CT shows airspace consolidations and ground-glass opacities.</p>
<h2 id="management">Management </h2>
<p>The majority of children with confirmed COVID-19 can be managed at home with good advice on hand hygiene, self-isolation and staying well hydrated. Hospital admission should be avoided wherever possible and is only indicated if the child requires oxygen therapy, feeding or fluid support or has a suspected bacterial infection.</p>
<h3 id="respiratory-care">Respiratory Care</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Oxygen therapy should be given if SpO2 &lt; 90%.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>If signs of severe pneumonia, shock, coma or convulsion aim for SpO2 ≥ 94%.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Infants and young children can use nasal prongs or cannula (maximum flow rate 2L/min). Older children and adolescents should receive oxygen via a face mask. Face masks with reservoir bags should be reserved for those with severe disease to deliver 10 – 15 L/min. Head boxes or other devices to maximise oxygen delivery should be used where possible.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>CPAP is not currently available for children with confirmed or suspected COVID-19.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Children with asthma should be treated as usual but with salbutamol given via a spacer rather than nebulized to reduce the risk of aerosolisation of COVID-19. Oral steroids should be used as normal for children with asthma.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Diagnosis of Acute Respiratory Distress Syndrome (ARDS) is based on ventilatory or oxygen requirements, which is not available in our setting.</p>
</div></li>
</ul>
<h3 id="supportive-care">Supportive Care</h3>
<p>Feeding and hydration are very important. If a child is not feeding well then nasogastric feeds or fluids should be considered before IV fluids.</p>
<p>If IV fluids are required for fluid resuscitation of a child or infant with COVID-19 and sepsis then Ringer’s Lactate given at maintenance volume would be first choice unless there is hypotension or poor perfusion. If hypotension or poor perfusion is present then Ringers Lactate should be given cautiously at 10-20 ml/kg over 30-60 minutes to a maximum of 40 ml/kg. If Ringers Lactate is unavailable then 0.9% normal saline, 0.9%/5% dextrose saline or 5% dextrose could be used depending on availability. There are concerns about liberal fluid use in severe COVID-19 being associated with poorer outcomes.</p>
<p>Maintenance Fluids for Infants and Children</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>100 ml/kg/day for the first 10 kg of weight</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>50 ml/kg/day for the second 10 kg of weight</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>20 ml/kg/day for the weight over 20 kg</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Over a 24 hour period, females are unlikely to need more than 2000 ml and males 2500 ml</p>
</div></li>
</ul>
<p>Infants and children of mothers with COVID-19 should continue to breastfeed freely, if clinically able.</p>
<p>Children with significant respiratory compromise should be fluid restricted to 2/3rds maintenance to reduce the risk of ARDS.</p>
<h3 id="fevers">Fevers</h3>
<p>First line antipyretic for children with a fever should be paracetamol. There is currently no significant evidence that ibuprofen is associated with worse outcomes in COVID-19 infection. If ibuprofen is prescribed regularly for a pre-existing medical condition (e.g. for rheumatoid arthritis) then this should be continued. Tepid sponging is not recommended.</p>
<h3 id="bacterial-infection">Bacterial infection</h3>
<p>Children who have signs and symptoms of sepsis at any stage in their illness, or if they are not clinically improving by day 3, should be assessed for possible bacterial infection and started on IV ceftriaxone following blood cultures within an hour of assessment. Duration of antibiotics should be guided by clinical course and blood culture results.</p>
<h3 id="monitoring-of-children-with-covid-19-infection">Monitoring of children with COVID-19 infection</h3>
<p>Hospitalised children need regular vital signs to identify deterioration.</p>
<h3 id="treatments-to-avoid">Treatments to avoid</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Although recommended in some papers for adults, the following medical treatments are not routinely recommended in children and may, in fact, have more side effects than potential beneficial effects: bronchodilators, steroids, antibiotics, antivirals and diuretics.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Angiotensin converting enzyme (ACE) inhibitors have not yet been shown to be harmful to children with COVID-19 infections. Patients taking ACE inhibitors for a pre-existing condition should continue them.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>There is no evidence at the time of writing (March 2020) to support any specific treatment for COVID-19 in children. The use of anti-virals is not currently recommended in children</p>
</div></li>
</ul>
<h3 id="research">Research</h3>
<p>Clinical trials for COVID-19 are ongoing so please consider whether each patient might be eligible.</p>
<h3 id="palliative">Palliative</h3>
<p>Please see separate guideline for advice on symptom-control and other considerations for the dying patient.</p>
<h3 id="discharge">Discharge</h3>
<p>Self-isolation of a child will need to follow Ministry of Health guidance where possible but this may need to be adjusted on a case-by-case basis.</p>
<h2 id="additional-information">Additional Information</h2>
<p>For the most current case definition and details of countries with transmission, please see <a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</a></p>
<h3 id="for-the-who-guidance-for-managing-covid-19-see-httpsapps.who.intirishandle10665331446">For the WHO guidance for managing COVID-19 see: <a href="https://apps.who.int/iris/handle/10665/331446"><span data-custom-style="Hyperlink">https://apps.who.int/iris/handle/10665/331446</span></a></h3>
<h2 id="online-resources">Online Resources:</h2>
<p><a href="https://www.ncbi.nlm.nih.gov/research/coronavirus/">https://www.ncbi.nlm.nih.gov/research/coronavirus/</a></p>
<p><a href="https://foamid.com/2020/03/17/covid-19-ultimate-resource-list/">https://foamid.com/2020/03/17/covid-19-ultimate-resource-list/</a></p>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>All the routine precautions for caring for patients with COVID-19 apply, see relevant guidelines.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Given increased demand on staffing and for the comfort of the children, it will still be important for children 15 years and under to have an escort present even if their escort is confirmed negative or asymptomatic.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Adults and children will be cohorted together on the same wards. Where possible, all children should be grouped together and be near to the nurses station to maintain their safety.</p>
</div></li>
</ul>
<h2 id="references">References</h2>
<p>Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts. medRxiv 2020. Available at: https://doi.org/10.1101/2020.03.03.20028423.</p>
<p>Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Pediatr. 2020. [Epub ahead of print]</p>
<p>Zimmermann P and Curtis N. Coronavirus Infections in Children Including COVID-19</p>
<p>An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. The Pediatric Infectious Disease Journal. 2020. [Epub ahead of print]</p>
<p>Lu D, Wang H, Yu R et al. Integrated infection control strategy to minimize nosocomial infection of corona virus disease 2019 among ENT healthcare workers. J Hosp Infect 2020 https://www.rcpch.ac.uk/sites/default/files/2020-03/bprs_management_of_children_admitted_to_hospital_with_covid19_-_20200319.pdf</p>
<p>Sinha I (2020) British Paediatric Respiratory Society. https://www.rcpch.ac.uk/sites/default/files/2020-03/bprs_management_of_children_admitted_to_hospital_with_covid19_-_20200319.pdf</p>
<p>Weiss SL, Peters MJ, Alhazzani W, et al. Management of Paediatric Septic Shock Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020 Feb;46(Suppl 1):10-67. doi: 10.1007/s00134-019-05878-6.</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Daisy Taylor</th>
<th>Date: 25 March 2020</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Baderinwa Abatan</td>
<td>Date: 01 April 2020</td>
</tr>
<tr class="even">
<td><strong>Reviewed by:</strong></td>
<td>Name: Helen Brotherton</td>
<td>Date: 10 April 2020</td>
</tr>
<tr class="odd">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="even">
<td>1.0</td>
<td>New document</td>
<td>10 April 2022</td>
</tr>
<tr class="odd">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
